Healthequity Stock Future Price Prediction

HQY
 Stock
  

USD 66.75  3.22  5.07%   

Healthequity stock price prediction is an act of determining the future value of Healthequity shares using few different conventional methods such as EPS estimation, analyst consensus, or fundamental intrinsic valuation. The successful prediction of Healthequity's future price could yield a significant profit. Please, note that this module is not intended to be used solely to calculate an intrinsic value of Healthequity and does not consider all of the tangible or intangible factors available from Healthequity's fundamental data. We analyze noise-free headlines and recent hype associated with Healthequity, which may create opportunities for some arbitrage if properly timed.
Please check Healthequity Basic Forecasting Models to cross-verify your projections.
  
Refresh
It is a matter of debate whether stock price prediction based on information in financial news can generate a strong buy or sell signal. We use our internally-built news screening methodology to estimate the value of Healthequity based on different types of headlines from major news networks to social media. The Healthequity stock price prediction module provides an analysis of price elasticity to changes in media outlook on Healthequity over a specific investment horizon.
Quarterly Earnings Growth YOY
-0.96
EPS Estimate Next Quarter
0.34
EPS Estimate Current Year
1.33
EPS Estimate Next Year
1.41
Wall Street Target Price
77.0
EPS Estimate Current Quarter
0.26
Quarterly Revenue Growth YOY
0.12
Using Healthequity hype-based prediction, you can estimate the value of Healthequity from the perspective of Healthequity response to recently generated media hype and the effects of current headlines on its competitors. We also analyze overall investor sentiment towards Healthequity using Healthequity's options and short interest. It helps to benchmark the overall future attitude of investors towards Healthequity using crowd psychology based on the activity and movement of Healthequity's stock price.
Healthequity Asset Turnover is fairly stable at the moment as compared to the past year. Healthequity reported Asset Turnover of 0.24 in 2021. Book Value per Share is likely to rise to 24.04 in 2022, whereas Calculated Tax Rate is likely to drop (133.82)  in 2022.

Healthequity Implied Volatility

    
  37.63  
Healthequity's implied volatility exposes the market's sentiment of Healthequity stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Healthequity's implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Healthequity stock will not fluctuate a lot when Healthequity's options are near their expiration.
This module is based on analyzing investor sentiment around taking a position in Healthequity. This speculative approach is based exclusively on the idea that markets are driven by emotions such as investor fear and greed. The fear of missing out, i.e., FOMO, can cause potential investors in Healthequity to buy its stock at a price that has no basis in reality. In that case, they are not buying Healthequity because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.

Healthequity after-hype prediction price

    
  $ 66.89  
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Sophisticated investors, who have witnessed many market ups and downs, frequently view the market will even out over time. This tendency of Healthequity's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy. Please use the tools below to analyze the current value of Healthequity in the context of predictive analytics.
Intrinsic
Valuation
LowReal ValueHigh
60.0872.1274.48
Details
Naive
Forecast
LowNext ValueHigh
60.5862.9465.30
Details
11 Analysts
Consensus
LowTarget PriceHigh
52.0064.8086.00
Details
Earnings
Estimates (7)
LowProjected EPSHigh
0.770.820.90
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Healthequity. Your research has to be compared to or analyzed against Healthequity's peers to derive any actionable benefits. When done correctly, Healthequity's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy towards taking a position in Healthequity.

Healthequity After-Hype Price Prediction Density Analysis

As far as predicting the price of Healthequity at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Healthequity or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many smart people who confused the symmetrical distributions of stock prices, such as prices of Healthequity, with the unreliable approximations that try to describe financial returns.
 Next price density 
      Expected price to next headline 

Healthequity Estimiated After-Hype Price Volatility

In the context of predicting Healthequity's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Healthequity's historical news coverage. Healthequity's after-hype downside and upside margins for the prediction period are 64.53 and 69.25, respectively. We have considered Healthequity's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value 66.75
66.89
After-hype Price
69.25
Upside
Healthequity is very steady asset. Analysis and calculation of next after-hype price of Healthequity is based on 3 months time horizon.

Healthequity Stock Price Prediction Analysis

Have you ever been surprised when a price of a company such as Healthequity is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Healthequity backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Healthequity, there might be something going there, and it might present an excellent short sale opportunity.
Expected ReturnPeriod VolatilityHype ElasticityRelated ElasticityNews DensityRelated DensityExpected Hype
  0.07  2.36  0.14   0.01  8 Events / Month0 Events / MonthIn about 8 days
Latest traded priceExpected after-news pricePotential return on next major newsAverage after-hype volatility
66.7566.890.21 
114.01  

Healthequity Hype Timeline

On the 30th of June Healthequity is traded for 66.75. The entity has historical hype elasticity of 0.14 and average elasticity to hype of competition of 0.01. Healthequity is projected to increase in value after the next headline with price projected to jump to 66.89 or above. The average volatility of media hype impact on the company stock price is about 114.01%. The price jump on the next news is forecasted to be 0.21% whereas the daily expected return is currently at -0.07%. The volatility of related hype on Healthequity is about 1685.71% with expected price after next announcement by competition of 66.76. The company reported the last year's revenue of 756.56 M. Reported Net Loss for the year was (44.29 M) with profit before taxes, overhead, and interest of 423.71 M. Considering the 90-day investment horizon the next projectedpress releasewill be in about 8 days.
Please check Healthequity Basic Forecasting Models to cross-verify your projections.

Healthequity Related Hype Analysis

Having access to credible news sources related to Healthequity's direct competition is more important than ever and may enhance your ability to predict Healthequity's future price movements. Getting to know how Healthequity rivals react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Healthequity may potentially react to the hype associated with one of its peers.

Healthequity Additional Predictive Modules

Most predictive techniques to examine Healthequity price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Healthequity using various technical indicators. When you analyze Healthequity charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

About Healthequity Predictive Indicators

The successful prediction of Healthequity stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Healthequity, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Healthequity based on analysis of Healthequity hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Healthequity's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Healthequity's related companies.
 2020 2021 2022 (projected)
Long Term Debt to Equity0.670.50.71
Interest Coverage1.011.161.19

Story Coverage note for Healthequity

The number of cover stories for Healthequity depends on current market conditions and Healthequity's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Healthequity is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Healthequity's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.

Healthequity Short Properties

Healthequity's future price predictability will typically decrease when Healthequity's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Healthequity often depends not only on the future outlook of the potential Healthequity's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Healthequity's indicators that are reflective of the short sentiment are summarized in the table below.
Shares Percent Shares Out4.94%
Short Percent Of Float5.64%
Float Shares82.16M
Shares Short Prior Month4.3M
Average Daily Volume Last 10 Day1.18M
Average Daily Volume In Three Month772.04k
Date Short Interest29th of April 2022
Please check Healthequity Basic Forecasting Models to cross-verify your projections. Note that the Healthequity information on this page should be used as a complementary analysis to other Healthequity's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.

Complementary Tools for Healthequity Stock analysis

When running Healthequity price analysis, check to measure Healthequity's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Healthequity is operating at the current time. Most of Healthequity's value examination focuses on studying past and present price action to predict the probability of Healthequity's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Healthequity's price. Additionally, you may evaluate how the addition of Healthequity to your portfolios can decrease your overall portfolio volatility.
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Go
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Go
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Go
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Go
Probability Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Go
Price Transformation
Use Price Transformation models to analyze depth of different equity instruments across global markets
Go
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Go
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Go
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Go
Is Healthequity's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Healthequity. If investors know Healthequity will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Healthequity listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth YOY
-0.96
Market Capitalization
5.5 B
Quarterly Revenue Growth YOY
0.12
Return On Assets
0.0059
Return On Equity
-0.0299
The market value of Healthequity is measured differently than its book value, which is the value of Healthequity that is recorded on the company's balance sheet. Investors also form their own opinion of Healthequity's value that differs from its market value or its book value, called intrinsic value, which is Healthequity's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Healthequity's market value can be influenced by many factors that don't directly affect Healthequity's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Healthequity's value and its price as these two are different measures arrived at by different means. Investors typically determine Healthequity value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Healthequity's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.